The premier meeting-place for the Clinical Trials sector in Central & Eastern Europe

28-29 May 2019

Read these exclusive interviews with leaders from Sanofi, Roche and Wockhardt Bio AG.


0001

Eddie Guzdar, Medical Head – Neuroscience, Sanofi Genzyme UKIE

How can the CT sector leverage new technologies to advance clinical research?

  • Automation and digitization of processes (informed consent, clinical trial recruitment, monitoring of investigator site), the interaction between patient, site and sponsor company…

0002

Alain Bindels, Head of Innovation Facilitation, Roche

How can the CT sector leverage new technologies to advance clinical research?

  • Automation and digitization of processes (informed consent, clinical trial recruitment, monitoring of investigator site), the interaction between patient, site and sponsor company…

0003

Piotr Iwanowski, National Board Member, Polish Association for Good Clinical Practice; VP Clinical Research Europe Wockhardt Bio AG, Zug, Switzerland

Will the review of clinical trial ethics be different under the EU Clinical Trial Regulation?

  • The answer is no and yes. No – with regards to the principles of ethics of clinical trial design and conduct. Yes – with regards to the way ethics committees operate…